Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome



Status:Completed
Conditions:Other Indications
Therapuetic Areas:Other
Healthy:No
Age Range:12 - 17
Updated:5/5/2014
Start Date:May 2011
End Date:January 2014
Contact:Novartis Pharmaceuticals
Phone:1-888-669-6682

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome

This Phase IIb study is designed to assess whether 3 doses of AFQ056 are safe and effective
in treating the behavioral symptoms of Fragile X Syndrome.


Inclusion Criteria:

- Patients with Fragile X Syndrome, who are at least moderately ill based on a Clinical
Global Impression Severity score of at least 4 and have qualifying scores on the
ABC-C and IQ test at Visit 1

Exclusion Criteria:

- Advanced, severe or unstable disease that may interfere with the study outcome
evaluations

- Cancer within the past 5 years, other than localized skin cancer

- Current treatment with more than two psychoactive medications, excluding
anti-epileptics

- History of severe self-injurious behavior

- Weigh less than 32 kg

- Females who are sexually active

Other protocol-defined inclusion/exclusion criteria may apply
We found this trial at
15
sites
Novartis Investigative Site
Decatur, Georgia 30030
433
mi
from 43215
Decatur, GA
Click here to add this to my saved trials
Novartis Investigative site
Aurora, Colorado 80010
1155
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
Novartis Investigative Site
Bellevue, Washington 98004
2000
mi
from 43215
Bellevue, WA
Click here to add this to my saved trials
Novartis Investigative site
Boston, Massachusetts 02118
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Novartis Investigator Site
Chicago, Illinois 60612
277
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Novartis Investigative site
Dallas, Texas 75216
914
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Novartis Investigative Site
Greenwood, South Carolina 29646
401
mi
from 43215
Greenwood, SC
Click here to add this to my saved trials
Novartis Investigative Site
Houston, Texas 77030
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Novartis Investigative Site
Indianapolis, Indiana 46202
167
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Novartis Investigative Site
Nashville, Tennessee 37205
339
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Novartis Investigative Site
Omaha, Nebraska 68144
691
mi
from 43215
Omaha, NE
Click here to add this to my saved trials
Novartis Investigative Site
Sacramento, California 95825
2039
mi
from 43215
Sacramento, CA
Click here to add this to my saved trials
Novartis Investigative Site
Seattle, Washington 98103
2007
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Novartis Investigative Site
Springfield, Massachusetts 01104
564
mi
from 43215
Springfield, MA
Click here to add this to my saved trials
Novartis Investigative Site
Staten Island, New York 10312
467
mi
from 43215
Staten Island, NY
Click here to add this to my saved trials